Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Multiple Myeloma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Immunoglobulin Light-chain Amyloidosis 6Vomiting 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Nausea 5Leukemia, Myeloid, Acute 5Leukemia 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma 4Hodgkin Disease 4Breast Neoplasms 4Blast Crisis 4Smoldering Multiple Myeloma 3Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Brain Neoplasms 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Lymphoma, Follicular 2

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × dexamethasone acetate × Clear all
NCT05773664 2024-09-19

Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma

City of Hope Medical Center

Phase 1 Withdrawn
CNS

Glioblastoma, Glioma

NCT01169415 2014-05-19

Effects of Steroid Tapering on Functional Capacity and Neurocognition

Duke University

Phase NA Withdrawn
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡